- - Gilead’s experimental HIV treatment meets main goal in late-stage trial

ReutersDecember 15, 2025 at 5:43 AM

0

Logos of Gilead at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov

Dec 15 (Reuters) - ​Gilead ‌Sciences said ‌on Monday ⁠its ‌experimental HIV ‍treatment met the ​main ‌goal in a ⁠late-stage ​trial.

(Reporting ​by Sriparna Roy ‍in ⁠Bengaluru; Editing ⁠by ‌Tasim ‌Zahid)

Original Article on Source

Source: “AOL Breaking”